NR-14土拉弗朗西斯菌亚种.holarctica,15(GaiskyLiveVaccineStrain)(细菌)
产品图片
货号/SKU
NR-14
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质，其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类：美国、2
产品描述信息
NR-14??Francisella tularensis subsp. holarctica, 15 (Gaisky Live Vaccine Strain)(Bacteria)|Francisella tularensis subsp. holarctica|15 (Gaisky Live Vaccine Strain)|-60°C or colder|ATCC?Acknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Francisella tularensis subsp. holarctica, Strain 15 (Gaisky Live Vaccine Strain), NR-14."| Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
Francisella tularensis (F. tularensis) subsp. holarctica, strain 15 was isolated from a water vole (Arvicola terrestris) by Gaisky in Russia (1936), where it was used as a live vaccine. Strain 15 was transferred from the Institute of Epidemiology and Microbiology (Gamaleia Institute) to the U. S. Army Medical Research Institute for Infectious Diseases (USAMRIID) in 1956.
F. tularensis subsp. holarctica, strain 15 was deposited to the ATCC ? in 1977 by J. Frederick Bell of the U.S. Public Health Service, National Institute of Allergy and Infectious Diseases, Rocky Mountain Laboratory in Montana. At the time of deposition this strain was known to produce two colony types (grey/black and blue variants) on blood agar plates and was considered a very attenuated strain of F. tularensis subsp. holarctica. F. tularensis subsp. holarctica, Live Vaccine Strain (LVS) was produced from five passages of the blue colony variant in mice and is available as BEI Resources NR-646.
NR-14 has been confirmed as subsp. holarctica (Type B) by PCR amplification of a subspecies-specific sequence of approximately 1250 bp from extracted DNA.
Each vial contains approximately 0.5 mL of bacterial culture in 0.5X Tryptic Soy Broth supplemented with 10% glycerol.
Francisella tularensis (F. tularensis) subsp. holarctica, strain 15 was isolated from a water vole (Arvicola terrestris) by Gaisky in Russia (1936), where it was used as a live vaccine. Strain 15 was transferred from the Institute of Epidemiology and Microbiology (Gamaleia Institute) to the U. S. Army Medical Research Institute for Infectious Diseases (USAMRIID) in 1956.
F. tularensis subsp. holarctica, strain 15 was deposited to the ATCC ? in 1977 by J. Frederick Bell of the U.S. Public Health Service, National Institute of Allergy and Infectious Diseases, Rocky Mountain Laboratory in Montana. At the time of deposition this strain was known to produce two colony types (grey/black and blue variants) on blood agar plates and was considered a very attenuated strain of F. tularensis subsp. holarctica. F. tularensis subsp. holarctica, Live Vaccine Strain (LVS) was produced from five passages of the blue colony variant in mice and is available as BEI Resources NR-646.
NR-14 has been confirmed as subsp. holarctica (Type B) by PCR amplification of a subspecies-specific sequence of approximately 1250 bp from extracted DNA.
Each vial contains approximately 0.5 mL of bacterial culture in 0.5X Tryptic Soy Broth supplemented with 10% glycerol.
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.在此限制上订单将在发货前发送至NIAID进行批准. Francisella tularensis （ f.tularensis ）subsp. Holarctica，菌株15从俄罗斯（1936年）的Gaisky（1936）中的水渣（Arvicola Terrestris）中分离出来，其中用作活疫苗. 1956年，应变15转移到流行病学和微生物学（Gamaleia Institute）的流行病学和微生物学（Gamaleia Institute）传染病（USAMRIID）转移到1956年. f. tularensis 子公司. Holarctica，菌株15于1977年由美国公共卫生服务，国家过敏和传染病研究所，蒙大拿州的岩石山实验室的J.Frederick贝尔沉积在ATCC?.在沉积时，已知该菌株在血液琼脂平板上产生两个菌落类型（灰色/黑色和蓝色变体），并且被认为是非常减弱的 f的菌株. tularensis 子公司. holarctica . f. tularensis 子公司. Holarctica ，活疫苗菌株（LVS）由小鼠的蓝色菌落变体的五个通道产生，可作为Bei Resources NR-646获得. NR-14已被确认为副.通过从提取的DNA中通过PCR扩增亚种特异性序列的PCR扩增，从提取的DNA的亚种特异性序列进行.补充有10％甘油.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立，旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中，可以监控科学界对这些材料的访问和使用，并确保试剂的质量控制。
除了为传染病界提供材料外，BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势，包括安全存储、社区访问和分发；同时保护存款人的知识产权。只要有需要，BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月， ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料，包括由其他政府支持的研究项目存放的材料，将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中，涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
可能感兴趣的内容
2024-01-21
2022-03-31
2021-12-02
2022-04-01
2020-08-04
2022-04-01
2021-12-02
2022-04-01
2021-12-21